Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2065392 | Toxicon | 2008 | 7 Pages |
In vivo microdialysis is a versatile sampling technique commonly employed to observe changes in neurotransmitters levels that occur in response to different treatments, being these treatments administered through a microdialysis probe implanted into a specific brain region in living animals. In previous works we have used this technique to study the effects of the drug anatoxin-a, a nicotinic acetylcholine receptor agonist, on dopamine release in striatum. The aim of the present study was to assess the recovery of anatoxin-a through the microdialysis probe. This information allows knowing the exact amount of the drug crossing the microdialysis membrane, acting on extracellular tissue. High Performance Liquid Chromatography (HPLC) with Fluorescence Detection (FLD) has been used for the analysis of anatoxin-a. We observed that the recovery of anatoxin-a was about 0.5%. Under our experimental conditions, the results suggest that anatoxin-a can be used as an important tool in the study of neuronal nicotinic receptors by in vivo microdialysis technique and also show a reliable estimation of the anatoxin-a recovery through the microdialysis probe under both in vivo and in vitro conditions.